0 Avaliações

ID

32675

Descrição

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:  Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

Palavras-chave

  1. 12/11/2018 12/11/2018 -
Titular dos direitos

GSK group of companies

Transferido a

12 de novembro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :


    Sem comentários

    Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

    A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904

    Serious Adverse Event Form

    Administrative data
    Descrição

    Administrative data

    Subject Identifier
    Descrição

    Subject Identifier

    Tipo de dados

    integer

    Centre Number
    Descrição

    Centre Number

    Tipo de dados

    integer

    Randomisation Number
    Descrição

    Randomisation Number

    Tipo de dados

    integer

    Serious Adverse Event (SAE)
    Descrição

    Serious Adverse Event (SAE)

    Did the subject experience a serious adverse event during the study?
    Descrição

    Did the subject experience a serious adverse event during the study?

    Tipo de dados

    boolean

    If YES, record details below
    Descrição

    If YES, record details below

    Tipo de dados

    text

    Section 1
    Descrição

    Section 1

    Event
    Descrição

    Diagnosis only (if known) Otherwise Sign/Symptom e.g., Anaphylaxis

    Tipo de dados

    text

    Start Date
    Descrição

    Start Date

    Tipo de dados

    date

    Start Time
    Descrição

    Start Time

    Tipo de dados

    time

    Outcome
    Descrição

    Outcome

    Tipo de dados

    text

    End Date
    Descrição

    If FATAL, record date of death

    Tipo de dados

    date

    End Time
    Descrição

    End Time

    Tipo de dados

    time

    Maximum Intensity
    Descrição

    Maximum Intensity

    Tipo de dados

    text

    Action Taken with Investigational Product(s) as a Result of the SAE
    Descrição

    Action Taken with Investigational Product(s) as a Result of the SAE

    Tipo de dados

    text

    Did the subject withdraw from study as a result of this SAE?
    Descrição

    Complete Study Conclusion page anf check Adverse Event as a reason for withdrawal.

    Tipo de dados

    boolean

    Is there a reasonable possibility the SAE may have been caused by the investigational product?
    Descrição

    Is there a reasonable possibility the SAE may have been caused by the investigational product?

    Tipo de dados

    boolean

    Section 2 - Seriousness
    Descrição

    Section 2 - Seriousness

    Specify reasons for considering this a SAE
    Descrição

    check YES for all that apply

    Tipo de dados

    text

    Results in death
    Descrição

    Results in death

    Tipo de dados

    boolean

    Is life-threatening
    Descrição

    Is life-threatening

    Tipo de dados

    boolean

    Requires hospitalisation or prolongation of existing hospitalisation
    Descrição

    Requires hospitalisation or prolongation of existing hospitalisation

    Tipo de dados

    boolean

    Results in disability/incapacity
    Descrição

    Results in disability/incapacity

    Tipo de dados

    boolean

    Congenital anomaly/birth defect
    Descrição

    Congenital anomaly/birth defect

    Tipo de dados

    boolean

    Other, specify
    Descrição

    Other, specify

    Tipo de dados

    text

    Section 3 - Demography Data
    Descrição

    Section 3 - Demography Data

    Date of Birth
    Descrição

    Date of Birth

    Tipo de dados

    date

    Sex
    Descrição

    Sex

    Tipo de dados

    text

    Weight
    Descrição

    Weight

    Tipo de dados

    float

    Unidades de medida
    • kg
    kg
    Section 4
    Descrição

    Section 4

    If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
    Descrição

    If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?

    Tipo de dados

    text

    Section 5 - Possible Causes of SAE
    Descrição

    Section 5 - Possible Causes of SAE

    Possible Causes other than Investgational Product
    Descrição

    check all that apply

    Tipo de dados

    integer

    If MEDICAL CONDITIONS, specify
    Descrição

    If MEDICAL CONDITIONS, specify

    Tipo de dados

    text

    If OTHER, specify
    Descrição

    If OTHER, specify

    Tipo de dados

    text

    Section 6 - Relevant Medical Conditions
    Descrição

    Section 6 - Relevant Medical Conditions

    Relevant past or current medical conditions
    Descrição

    specify all relevant past or current medical disorders, allergies, surgeries, etc. that can help explain the SAE

    Tipo de dados

    text

    Date of Onset
    Descrição

    Date of Onset

    Tipo de dados

    date

    Condition present at Time of the SAE
    Descrição

    Condition present at Time of the SAE

    Tipo de dados

    boolean

    If NO, Date of Last Occurrence
    Descrição

    If NO, Date of Last Occurrence

    Tipo de dados

    date

    Section 7 - Relevant Risk Factors
    Descrição

    Section 7 - Relevant Risk Factors

    Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
    Descrição

    Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)

    Tipo de dados

    text

    Section 8 - Relevant Concomitant Medications
    Descrição

    Section 8 - Relevant Concomitant Medications

    Drug Name
    Descrição

    Trade name preferred e.g., Zantac

    Tipo de dados

    text

    Dose
    Descrição

    Dose

    Tipo de dados

    float

    Unit
    Descrição

    Unit

    Tipo de dados

    text

    Frequency
    Descrição

    Frequency

    Tipo de dados

    text

    Route
    Descrição

    Route

    Tipo de dados

    text

    Taken Prior to Study
    Descrição

    Taken Prior to Study

    Tipo de dados

    boolean

    Start Date
    Descrição

    Start Date

    Tipo de dados

    date

    Stop Date
    Descrição

    Stop Date

    Tipo de dados

    date

    Ongoing Medication
    Descrição

    Ongoing Medication

    Tipo de dados

    boolean

    Reason for Medication
    Descrição

    e.g., Gastric ulcer

    Tipo de dados

    text

    Section 9 - Investigational Product
    Descrição

    Section 9 - Investigational Product

    Record details of investigational product
    Descrição

    Record details of investigational product

    Tipo de dados

    text

    Section 10 - Relevant Assessment
    Descrição

    Section 10 - Relevant Assessment

    Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
    Descrição

    e.g., laboratory data with units and normal range

    Tipo de dados

    text

    Section 11 - Narrative Remarks
    Descrição

    Section 11 - Narrative Remarks

    Provide a brief narrative description of the SAE and details of treatment given
    Descrição

    Provide a brief narrative description of the SAE and details of treatment given

    Tipo de dados

    text

    Administrative data
    Descrição

    Administrative data

    Investigator's signature
    Descrição

    confirming that the data on the SAE pages are accurate and complete

    Tipo de dados

    text

    Investigator's name (print)
    Descrição

    Investigator's name (print)

    Tipo de dados

    text

    Date
    Descrição

    Date

    Tipo de dados

    date

    Similar models

    Serious Adverse Event Form

    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de dados
    Alias
    Item Group
    Administrative data
    Subject Identifier
    Item
    Subject Identifier
    integer
    Centre Number
    Item
    Centre Number
    integer
    Randomisation Number
    Item
    Randomisation Number
    integer
    Item Group
    Serious Adverse Event (SAE)
    Did the subject experience a serious adverse event during the study?
    Item
    boolean
    If YES, record details below
    Item
    If YES, record details below
    text
    Item Group
    Section 1
    Event
    Item
    Event
    text
    Start Date
    Item
    Start Date
    date
    Start Time
    Item
    Start Time
    time
    Item
    Outcome
    text
    Code List
    Outcome
    CL Item
    Recovered/Resolved (1)
    CL Item
    Recovering/Resolving (2)
    CL Item
    Not recovered/Not resolved (3)
    CL Item
    Recovered/Resolved with sequelae (4)
    CL Item
    Fatal (5)
    End Date
    Item
    End Date
    date
    End Time
    Item
    End Time
    time
    Item
    Maximum Intensity
    text
    Code List
    Maximum Intensity
    CL Item
    Mild (1)
    CL Item
    Moderate (2)
    CL Item
    Severe (3)
    CL Item
    Not applicable (4)
    Item
    Action Taken with Investigational Product(s) as a Result of the SAE
    text
    Code List
    Action Taken with Investigational Product(s) as a Result of the SAE
    CL Item
    Investigational product(s) withdrawn (1)
    CL Item
    Dose reduced (2)
    CL Item
    Dose increased (3)
    CL Item
    Dose not changed (4)
    CL Item
    Dose interrupted (5)
    CL Item
    Not applicable (6)
    Did the subject withdraw from study as a result of this SAE?
    Item
    Did the subject withdraw from study as a result of this SAE?
    boolean
    Is there a reasonable possibility the SAE may have been caused by the investigational product?
    Item
    Is there a reasonable possibility the SAE may have been caused by the investigational product?
    boolean
    Item Group
    Section 2 - Seriousness
    Specify reasons for considering this a SAE
    Item
    Specify reasons for considering this a SAE
    text
    Results in death
    Item
    Results in death
    boolean
    Is life-threatening
    Item
    Is life-threatening
    boolean
    Requires hospitalisation or prolongation of existing hospitalisation
    Item
    Requires hospitalisation or prolongation of existing hospitalisation
    boolean
    Results in disability/incapacity
    Item
    Results in disability/incapacity
    boolean
    Congenital anomaly/birth defect
    Item
    Congenital anomaly/birth defect
    boolean
    Other, specify
    Item
    Other, specify
    text
    Item Group
    Section 3 - Demography Data
    Date of Birth
    Item
    Date of Birth
    date
    Item
    Sex
    text
    Code List
    Sex
    CL Item
    Male (1)
    CL Item
    Female (2)
    Weight
    Item
    Weight
    float
    Item Group
    Section 4
    Item
    If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
    text
    Code List
    If Investigational Product(s) was stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were administered?
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown at this time (3)
    CL Item
    Not applicable (4)
    Item Group
    Section 5 - Possible Causes of SAE
    Item
    Possible Causes other than Investgational Product
    integer
    Code List
    Possible Causes other than Investgational Product
    CL Item
    Disease under study (1)
    CL Item
    Medical condition(s) (2)
    CL Item
    Lack of efficacy (3)
    CL Item
    Withdrawal of investigational product(s) (4)
    CL Item
    Concomitant medication(s) (record details in Section 8 below) (5)
    CL Item
    Activity related to study participation (e.g., procedures) (6)
    CL Item
    Other (7)
    If MEDICAL CONDITIONS, specify
    Item
    If MEDICAL CONDITIONS, specify
    text
    If OTHER, specify
    Item
    If OTHER, specify
    text
    Item Group
    Section 6 - Relevant Medical Conditions
    Relevant past or current medical conditions
    Item
    Relevant past or current medical conditions
    text
    Date of Onset
    Item
    Date of Onset
    date
    Condition present at Time of the SAE
    Item
    Condition present at Time of the SAE
    boolean
    If NO, Date of Last Occurrence
    Item
    If NO, Date of Last Occurrence
    date
    Item Group
    Section 7 - Relevant Risk Factors
    Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
    Item
    Record other relevant risk factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
    text
    Item Group
    Section 8 - Relevant Concomitant Medications
    Drug Name
    Item
    Drug Name
    text
    Dose
    Item
    Dose
    float
    Unit
    Item
    Unit
    text
    Frequency
    Item
    Frequency
    text
    Route
    Item
    Route
    text
    Taken Prior to Study
    Item
    Taken Prior to Study
    boolean
    Start Date
    Item
    Start Date
    date
    Stop Date
    Item
    Stop Date
    date
    Ongoing Medication
    Item
    Ongoing Medication
    boolean
    Reason for Medication
    Item
    Reason for Medication
    text
    Item Group
    Section 9 - Investigational Product
    Record details of investigational product
    Item
    Record details of investigational product
    text
    Item Group
    Section 10 - Relevant Assessment
    Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
    Item
    Provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE
    text
    Item Group
    Section 11 - Narrative Remarks
    Provide a brief narrative description of the SAE and details of treatment given
    Item
    Provide a brief narrative description of the SAE and details of treatment given
    text
    Item Group
    Administrative data
    Investigator's signature
    Item
    Investigator's signature
    text
    Investigator's name (print)
    Item
    Investigator's name (print)
    text
    Date
    Item
    Date
    date

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial